Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Nature Reviews. Nephrology
|
July 18, 2012
Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy
Manuel Praga, Jorge Rojas-Rivera
The New England Journal of Medicine
|
January 26, 2021
Belimumab in Lupus Nephritis
Jorge Rojas-Rivera, Alberto Ortiz, Sol Carriazo
The New England Journal of Medicine
|
December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease
Jorge Rojas-Rivera, Sol Carriazo, Alberto Ortiz
International Journal of Nephrology
|
June 16, 2012
Antioxidants in kidney diseases: the impact of bardoxolone methyl
Jorge Rojas-Rivera, Alberto Ortiz, Jesus Egido
Kidney International
|
April 24, 2021
The authors reply
Gema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Kidney International
|
March 22, 2021
The authors reply
Gema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Clinical Kidney Journal
|
September 29, 2015
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?
Jorge Rojas-Rivera, Gema Fernández-Juárez, Manuel Praga
Drugs
|
December 21, 2021
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
Jorge Rojas-Rivera, Fernando C Fervenza, Alberto Ortiz
Clinical Kidney Journal
|
June 13, 2015
Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
Enrique Morales, Rafael Morales, Eduardo Gutiérrez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
November 1, 2015
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria
Enrique Morales, Eduardo Gutiérrez, Jara Caro, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Nature Reviews. Nephrology
|
July 18, 2012
Glomerular disease: Predicting outcomes in idiopathic membranous nephropathy
Manuel Praga, Jorge Rojas-Rivera
The New England Journal of Medicine
|
January 26, 2021
Belimumab in Lupus Nephritis
Jorge Rojas-Rivera, Alberto Ortiz, Sol Carriazo
The New England Journal of Medicine
|
December 28, 2022
Daprodustat and On-Treatment Cardiovascular Events in Chronic Kidney Disease
Jorge Rojas-Rivera, Sol Carriazo, Alberto Ortiz
International Journal of Nephrology
|
June 16, 2012
Antioxidants in kidney diseases: the impact of bardoxolone methyl
Jorge Rojas-Rivera, Alberto Ortiz, Jesus Egido
Kidney International
|
April 24, 2021
The authors reply
Gema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Kidney International
|
March 22, 2021
The authors reply
Gema Fernández-Juárez, Jorge Rojas-Rivera, Manuel Praga
Clinical Kidney Journal
|
September 29, 2015
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?
Jorge Rojas-Rivera, Gema Fernández-Juárez, Manuel Praga
Drugs
|
December 21, 2021
Recent Clinical Trials Insights into the Treatment of Primary Membranous Nephropathy
Jorge Rojas-Rivera, Fernando C Fervenza, Alberto Ortiz
Clinical Kidney Journal
|
June 13, 2015
Raloxifene and Bevacizumab for severe complications of hereditary haemorrhagic telangiectasia in a haemodialysis patient
Enrique Morales, Rafael Morales, Eduardo Gutiérrez, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
November 1, 2015
Beneficial long-term effect of aldosterone antagonist added to a traditional blockade of the renin-angiotensin-aldosterone system among patients with obesity and proteinuria
Enrique Morales, Eduardo Gutiérrez, Jara Caro, et al.
Page
of 3